These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1434267)

  • 1. [A study of inhibitory effect of chondroitin polysulfate on stone formation of calcium oxalate].
    Fujisawa M; Arima S; Yachiku S
    Nihon Hinyokika Gakkai Zasshi; 1992 Oct; 83(10):1647-54. PubMed ID: 1434267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of sodium pentosan polysulphate and certain inhibitors on calcium oxalate crystal growth.
    Senthil D; Subha K; Saravanan N; Varalakshmi P
    Mol Cell Biochem; 1996 Mar; 156(1):31-5. PubMed ID: 8709973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of crystallization on urolithiasis in vitro].
    Miyazawa K; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1991 Oct; 37(10):1091-6. PubMed ID: 1721765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies of sodium pentosan polysulphate (SPP) therapy on the urinary stone disease. Experimental studies on the calcium oxalate crystallization and the effects in healthy subjects].
    Fukatani T
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):246-53. PubMed ID: 1710303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of urine on "in vitro" crystallization rate of calcium oxalate: determination of inhibitory activity by a [14C]oxalate technique.
    Ligabue A; Fini M; Robertson WG
    Clin Chim Acta; 1979 Oct; 98(1-2):39-46. PubMed ID: 227625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentosan polysulfate as an inhibitor of calcium oxalate crystal growth.
    Martin X; Werness PG; Bergert JH; Smith LH
    J Urol; 1984 Oct; 132(4):786-8. PubMed ID: 6206244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preventive effect of sodium pentosan polysulfate against renal stone formation in hyperoxaluric rats.
    Nakatani T; Ishii K; Yoneda Y; Kamikawa S; Kanazawa T; Sugimoto T; Osswald H
    Urol Res; 2002 Oct; 30(5):329-35. PubMed ID: 12389123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulphate in calcium oxalate urolithiasis.
    Grases F; Genestar C; Conte A; March P; Costa-Bauzá A
    Br J Urol; 1989 Sep; 64(3):235-7. PubMed ID: 2553195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of pH on the urinary inhibition of calcium oxalate crystal growth.
    Tiselius HG
    Br J Urol; 1981 Oct; 53(5):470-4. PubMed ID: 6793122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory effect of sodium pentosan polysulfate on the formation, growth and aggregation of calcium oxalate in vitro].
    Suzuki K; Miyazawa K; Tsugawa R
    Nihon Hinyokika Gakkai Zasshi; 1989 Apr; 80(4):526-31. PubMed ID: 2473238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role for pentosan polysulfate in the prevention of calcium oxalate stones?
    Jones M; Monga M
    J Endourol; 2003 Dec; 17(10):855-8. PubMed ID: 14744348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of calcium oxalate crystallization and urolithiasis.
    Grases F; Conte A; Genestar C; Costa-Bauzá A
    Urol Int; 1992; 48(4):409-14. PubMed ID: 1413303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium pentosan polysulphate--a novel inhibitor of urinary risk factors and enzymes in experimental urolithiatic rats.
    Senthil D; Malini MM; Varalakshmi P
    Ren Fail; 1998 Jul; 20(4):573-80. PubMed ID: 9713875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of magnesium on calcium oxalate urolithiasis.
    Su CJ; Shevock PN; Khan SR; Hackett RL
    J Urol; 1991 May; 145(5):1092-5. PubMed ID: 2016799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of urinary macromolecules and chondroitin sulphate on calcium oxalate crystallization in urine.
    Rodgers AL; Ball D; Harper W
    Scanning Microsc; 1994 Mar; 8(1):71-7. PubMed ID: 7973501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of urinary pH and acid-base balance on the formation of calcium oxalate stone].
    Iida S
    Nihon Hinyokika Gakkai Zasshi; 1991 Jan; 82(1):33-40. PubMed ID: 2046198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
    Gohel MD; Shum DK; Tam PC
    Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of stone formation.
    Worcester EM
    Semin Nephrol; 1996 Sep; 16(5):474-86. PubMed ID: 8890402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface interaction between glycosaminoglycans and calcium oxalate.
    Angell AH; Resnick MI
    J Urol; 1989 May; 141(5):1255-8. PubMed ID: 2709520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of urinary material and glycosaminoglycans on calcium oxalate monohydrate crystal aggregation].
    Shirane Y; Yamamoto A; Mizuta K; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):1000-3. PubMed ID: 2514310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.